StrongIncrease
GLP-1
Group Meeting → GLP-1
Group Meeting → GLP-1
Evidence profile
StrongIncreaseMetabolic Health
Unlock full evidence details
Research Summary
Analyzed using Evidence Intelligence™
Educational Visits Improve Metformin Prescribing for Type 2 Diabetes
Key finding
The use of metformin increased by 5.9% after the individual AD visit.
This study evaluated the impact of academic detailing and group visits on prescribing practices for Type 2 Diabetes, finding significant increases in metformin and insulin prescriptions.
Evidence strength
Moderate confidence
Study type
RCTs
Follow-up
Long-Term (1–5 y)
Some Concerns bias
Last updated July 5, 2026Quick read
Study at a glance
The essential study design details in one scan.
Population
Young Adult (19–39), Middle Aged (40-64), Male, Female, Asia-Pacific (APAC), with T2 Diabetes
Intervention
Individual Academic Detailing Visit, Group Meeting, Control (No walking)
Study type
RCTs
Follow-up
Long-Term (1–5 y)
Primary outcome
Metformin Prescribing
Comparator
No intervention
Plain-language summary
What this paper says
A plain-language read of the study's main message and where it applies.
Study focus
This study evaluated the impact of academic detailing and group visits on prescribing practices for Type 2 Diabetes, finding significant increases in metformin and insulin prescriptions.
Clinical relevance
Improving prescribing practices for Type 2 Diabetes is crucial for patient management and outcomes. The significant increases in medication prescriptions following targeted interventions suggest that educational strategies can effectively enhance clinical practice and patient care.
Keep in mind
The study's effectiveness remains unclear due to limited data on long-term outcomes. The sample size and demographic diversity may limit generalizability. The control group did not receive any intervention, which may affect comparative results.
Published in
Journal Reference
Publication details and source links for this paper.
Harald CL, Øyvind S, Roar D, Hege SB, Olav S. Impact of Academic Detailing and Group Visits on Prescribing for Type 2 Diabetes: A Randomized Controlled Trial. Journal of General Internal Medicine. 2024;39(16):3243-3252. doi:10.1007/s11606-024-09014-z
Save this study and add notes to your research library.
Main Effects
Metformin prescribing increased by 5.9% after the individual AD visit (p=0.006).
Insulin prescribing increased by 19.1% after the group meeting (p=0.001).
GLP-1 analogues prescribing increased by 32.2% after the group meeting.
Evidence network
How this study fits
Understand where this research contributes within the broader evidence network.
Evidence Context
This study contributes evidence to Group Meeting, Individual Academic Detailing Visit and GLP-1, Insulin Prescribing, Metformin Prescribing, and 1 more.
This study contributes evidence to
Primary intervention
Group Meeting
Primary outcomes
- GLP-1
- Insulin Prescribing
- Metformin Prescribing
Primary intervention
Primary outcomes
Evidence relationships
Intervention and outcome relationships this study adds to the evidence network.
8
Evidence pairs
8
Relationships
0
Evidence topics
contributes_evidence
Editorial context
Why this study matters
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
Moderate contributionModerate confidenceNetwork score: 50
0
Related topics
8
Evidence pairs
0
Related studies
Why it is useful
- Contributes to 8 evidence relationships
- Includes primary outcome data
- Linked to 0 direct semantic evidence topics
Core evidence
Study findings
The primary outcomes reported in this study.
StrongIncrease
Insulin Prescribing
Group Meeting → Insulin Prescribing
Group Meeting → Insulin Prescribing
Evidence profile
StrongIncreaseClinical Outcomes
Unlock full evidence details
StrongIncrease
Metformin Prescribing
Group Meeting → Metformin Prescribing
Group Meeting → Metformin Prescribing
Evidence profile
StrongIncreaseClinical Outcomes
Unlock full evidence details
StrongIncrease
Total T2D Drugs Prescribing
Group Meeting → Total T2D Drugs Prescribing
Group Meeting → Total T2D Drugs Prescribing
Evidence profile
StrongIncreaseClinical Outcomes
Unlock full evidence details
StrongIncrease
GLP-1
Individual Academic Detailing Visit → GLP-1
Individual Academic Detailing Visit → GLP-1
Evidence profile
StrongIncreaseMetabolic Health
Unlock full evidence details
StrongIncrease
Insulin Prescribing
Individual Academic Detailing Visit → Insulin Prescribing
Individual Academic Detailing Visit → Insulin Prescribing
Evidence profile
StrongIncreaseClinical Outcomes
Unlock full evidence details
StrongIncrease
Metformin Prescribing
Individual Academic Detailing Visit → Metformin Prescribing
Individual Academic Detailing Visit → Metformin Prescribing
Evidence profile
StrongIncreaseClinical Outcomes
Unlock full evidence details
StrongIncrease
Total T2D Drugs Prescribing
Individual Academic Detailing Visit → Total T2D Drugs Prescribing
Individual Academic Detailing Visit → Total T2D Drugs Prescribing
Evidence profile
StrongIncreaseClinical Outcomes
Unlock full evidence details
Unlock full evidence analysis
Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.
Evidence Suggest
- Metformin prescribing rose by 5.9% after individual visits.
- Insulin prescriptions increased by 19.1% following group meetings.
- GLP-1 analogue prescribing increased by 32.2% after group meetings.
Who this applies to
- Adults diagnosed with Type 2 Diabetes.
- Healthcare providers involved in diabetes management.
Keep in Mind
- The study's findings may not apply to all healthcare settings.
- The impact of interventions on long-term patient outcomes is not fully assessed.
- Variability in provider engagement during interventions could influence results.
Between the Lines
- The study's effectiveness remains unclear due to limited data on long-term outcomes.
- The sample size and demographic diversity may limit generalizability.
- The control group did not receive any intervention, which may affect comparative results.
Unlock Full Analysis
Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.
Already have an account?
Connected Evidence
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Group Meeting and GLP-1, Group Meeting and Insulin Prescribing.
Related evidence relationships
Explore in Evidence ArchiveThis study contributes to the evidence on the following intervention-outcome relationships.
Included in these evidence collections
Curated evidence collections and hubs this study is part of.
GLP-1 Evidence Hub
All studies measuring GLP-1
1 studies
outcome_hubMeasures GLP-1 as a key outcome.
Group Meeting Evidence Hub
All studies on Group Meeting
1 studies
intervention_hubContributes to Group Meeting evidence base.
Insulin Prescribing Evidence Hub
All studies measuring Insulin Prescribing
1 studies
outcome_hubMeasures Insulin Prescribing as a key outcome.
Recent Diabetes Research
Latest published studies
recency_collection
Published within the last 2 years.
Explore more in the evidence archive
Jump to pre-filtered views in the evidence archive.
All studies on Group Meeting and GLP-1
Intervention: Group MeetingOutcome: GLP-1
1 results
All studies on Group Meeting and Insulin Prescribing
Intervention: Group MeetingOutcome: Insulin Prescribing
1 results
All studies on Group Meeting
Intervention: Group Meeting
1 results
All studies measuring GLP-1
Outcome: GLP-1
1 results
All studies measuring Insulin Prescribing
Outcome: Insulin Prescribing
1 results
Questions answered by this study
Generated from the study's connected evidence using Evidence Intelligence™.
Does Group Meeting improve glp-1?
Emerging Evidence
Group Meeting appears to improve GLP-1.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
GLP-1
EvidenceScore™ Emerging | EvidenceScore™ 52.9 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Group Meeting improve insulin prescribing?
Emerging Evidence
Group Meeting appears to improve Insulin Prescribing.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Insulin Prescribing
EvidenceScore™ Emerging | EvidenceScore™ 52.9 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Group Meeting improve metformin prescribing?
Emerging Evidence
Group Meeting appears to improve Metformin Prescribing.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Metformin Prescribing
EvidenceScore™ Emerging | EvidenceScore™ 52.9 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Group Meeting improve total t2d drugs prescribing?
Emerging Evidence
Group Meeting appears to improve Total T2D Drugs Prescribing.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Total T2D Drugs Prescribing
EvidenceScore™ Emerging | EvidenceScore™ 52.9 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Next steps
Continue your research
Choose a next path through related evidence topics, archive views, and research summaries.
Explore in archive
Open broader archive views for this relationship.
Related research
Read related research summaries.
Telemonitoring improves glycemic control in pediatric diabetesHome resistance training and leisure activity both improve blood sugar and boost helpful GLP-1 hormone in children with type 1 diabetesCitrus Bioflavonoids Improve Metformin Efficacy in PrediabetesF-Biotic™ improves glycemic control in adults with type 2 diabetesGreen tea extract may improve insulin resistance in type 2 diabetes patients
No ads. No tracking.
Focused on evidence, not advertising.
Secure & private
Your data is always protected.
Always up to date
New studies added every day.